# LYTENAVA
> **BLA761320** · Biologics License Application · Sponsor: OUTLOOK THERAPEUTICS, INC. · Approved 2026-07-24
## Drug
- **FDA Application Number:** BLA761320
- **Application type:** Biologics License Application
- **Brand name:** LYTENAVA
- **Generic name:** Bevacizumab-Vikg
- **Active ingredients:** BEVACIZUMAB-VIKG
- **Dosage form:** VIAL
- **Route:** SINGLE-DOSE
- **Marketing status:** Prescription
- **Sponsor:** OUTLOOK THERAPEUTICS, INC.
- **First approval:** 2026-07-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761320)
---
*MORVS · CC0 1.0*